Feed Top Reports Pricing

⌘K

12:42:54·1d

SECFilingvia Quantisnow

SEC Form DEFA14A filed by nLIGHT Inc.

ByQuantisnow·Wall Street's wire, on your screen.

LASR· nLIGHT Inc.

Technology

Original source

This insight was delivered by Quantisnow - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LASR (nLIGHT Inc.) and more on Quantisnow.

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Companies

LASR
nLIGHT Inc.
Technology

Recent analyst ratings

Mar 27UpdateWilliam Blair-
Mar 4UpdateRobert W. Baird-
Jan 20UpdateStifel$60.00
Nov 7UpdateThe Benchmark Company$40.00
May 9UpdateCraig Hallum$14.00
Oct 3UpdateCantor Fitzgerald$15.50

Related

SEC1d
SEC Form DEF 14A filed by nLIGHT Inc.
PR12d
nLIGHT to Announce First Quarter 2026 Financial Results on May 7th
SEC29d
Amendment: SEC Form SCHEDULE 13G/A filed by nLIGHT Inc.
ANALYST29d
William Blair initiated coverage on nLIGHT
INSIDER42d
Director Link Raymond A sold $1,612,652 worth of shares (25,404 units at $63.48), decreasing direct ownership by 25% to 77,172 units (SEC Form 4)
INSIDER42d
Chief Accounting Officer Nias James sold $116,471 worth of shares (1,808 units at $64.42), decreasing direct ownership by 2% to 93,899 units (SEC Form 4)
INSIDER44d
Director Locke Gary exercised 69,725 shares at a strike of $1.45, increasing direct ownership by 163% to 112,574 units (SEC Form 4)
INSIDER44d
President and CEO Keeney Scott H sold $1,122,755 worth of shares (19,096 units at $58.80), decreasing direct ownership by 0.86% to 2,210,029 units (SEC Form 4)

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releases Analyst ratings Insider trading FDA SEC RSS feeds

Top lists

Trending By market cap Active companies Analyst upgrades Insider purchases FDA approvals SEC filings Sectors Market reports

Company

About Pricing Publish with us Contact

Legal

Terms of use Privacy policy Cookie policy

© 2026 quantisnow.com · Democratizing insights since 2022